Reprogramming technology has enabled the fate conversion of terminally differenti- For a long time, it had been believed that once a cell differentiates into a final cell state, it permanently loses the potential to diversify its functions and stably maintains its identity. Similarly, it is generally accepted that age-related changes including cellular senescence are irreversible processes. The classic concept of unidirectional differentiation was presented by Waddington and is known as the epigenetic landscape model. Consistent with the stable maintenance of cellular identity, cell fate conversion, such as dedifferentiation and transdifferentiation, are restricted to certain conditions, such as tissue regeneration and cancer development. However, we now know that this dogma is not always true and that cell fate can be altered by artificial reprogramming technology.
totipotent state when it is transferred into an enucleated oocyte. 1, 2 Similarly, when a somatic cell is fused with an embryonic stem cell, a subset of the embryonic program is initiated in its nucleus. 3, 4 Finally, the landmark study by Takahashi and Yamanaka revealed that the induction of a certain set of transcription factors (Oct3/4, Sox2, Klf4 and c-Myc; OSKM) highly expressed in embryonic stem cells can confer the gene expression profiles and the epigenetic landscape of pluripotent stem cells on differentiated cells, resulting in induced pluripotent stem cells (iPSCs). 5, 6 In addition, starting with the first report, which showed that the ectopic expression of MyoD, a myoblast determination gene, is sufficient to reprogram mouse fibroblasts into myoblasts in vitro, 7 a number of experiments have shown that the forced expression of lineage-specific transcription factors successfully induces direct reprogramming, which converts one differentiated cell type into another without dedifferentiating to the pluripotent state. 8, 9 Based on these studies, the Waddington model of cell differentiation has been revised, and it is now widely accepted that cell fate can be converted by artificial manipulations.
Although most cellular reprogramming strategies have been developed in vitro, in vivo reprogramming strategies, which describe the fate conversion of differentiated somatic cells to another cell type in a mammalian body, have been developing rapidly in recent years. In vivo reprogramming technology can serve as a potential novel strategy for regenerative medicine. Moreover, recent studies suggest that the technology could be a powerful tool for unveiling biological phenomena related to epigenetic regulation in tissue regeneration, aging, rejuvenation, and cancer development in multicellular organisms.
| EPIGEN ETIC REGULATION EN SURES STABLE MAINTENANCE OF CELL FATE
Epigenetics is defined as the meitotically and mitotically inherited regulation of gene expressions that are not accompanied by alteration of the DNA sequence. 10 The stable maintenance of somatic cell identity is governed by various epigenetic modifications, such as DNA methylation, histone modifications, and chromatin structure.
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During development, epigenetic regulation plays a central role in the establishment and maintenance of stable gene expression signatures.
Once cells differentiate and lineage commitment occurs, DNA methylation and histone modification profiles are faithfully maintained as the cells divide. It is known that multiple enzymatic systems, which include DNA methyltransferases, histone acetylases, deacetylases, methylases, and demethylases, as well as protein complexes implicated in chromatin remodeling, maintain epigenetic regulation. 11 Overall, cell fate conversion requires a dynamic reorganization of the epigenetic regulation that overcomes this maintenance machinery.
Because somatic cell fate is stably maintained, it is assumed that epigenetic regulation in somatic cells is stably maintained as well.
Given that epigenetic regulation interconnects environmental stimuli with the genome, epigenetic alterations could occur when cells in tissues are exposed to continuous and/or strong external signals. The upregulation of utx-1 removes H3K27me3, and the concomitant decrease in H3K27me3 takes place with aging in C. elegans. 18 Conversely, the depletion of utx-1 increases H3K27me3 levels and extends lifespan. 19 Together, these results support a model that claims a gain of activating histone marks and loss of repressive histone marks, which are both representative epigenetic alterations during aging, play a role in lifespan ( Figure 1 ). Figure 2 ).
| HISTONE MODIFICATION S IN SENESCENT CELLS
Notably, the increased expression of SASP genes in senescent cells often correlates with decreased H3K27me3 deposition. 30 Additionally, the inhibition of the H3K4 methyltransferase MLL1 inhibits SASP, 41 suggesting that SASP is governed by altered histone modifications. The impact of H3K27me3 on senescence is further highlighted by the fact that the overexpression of BMI1, which causes increased EZH2 and increased H3K27me3 deposition at the INK4A-ARF locus, ameliorates senescence-related phenotypes. 31 Taken together, altered histone deposition and modifications that are associated with transcriptional changes have a profound impact on organismal lifespan and senescence-associated phenotypes in diverse organisms.
| DNA METHYLATION IN SE NESCE NT CELLS
An alteration of DNA methylation patterns occurs during aging and senescence in mammals. These senescence-associated DNA methylation changes are significantly enriched in genomic regions with repressive histone marks and at target sites of Polycomb group proteins. 42, 43 As cells undergo aging, DNA methylation levels are decreased gradually during premature and replicative senescence. 44 Although DNA hypomethylation is common with aging, some regions actually become hypermethylated. 45 The loci that display age-dependent DNA hypermethylation include tissue-specific genes, genes involved in differentiation and development, genes encoding transcription factors, and transcription factor binding sites. 45 Indeed, centenarian DNA has lower DNA methylation content globally, but
higher DNA methylation at CpG island promoters. 46 Consistent with were first described as a reduction of global DNA methylation levels. 50 A majority of cancers harbor changes in DNA methylation, which include genome-wide DNA hypomethylation as well as sitespecific de novo DNA methylation. 11 Mechanistically, such hypomethylation has been connected with genomic instability. 51 In contrast, DNA hypermethylation has been often linked to the silencing of neighboring genes that are functionally related to tumor suppression in many cancers. 52 Taken together, the current consensus holds that epigenetic alterations promote cancer development.
| IN VIVO STUDIES THAT INVESTIGATE D THE ROLE OF EPIGENETIC REGULATION IN CANCER DEVELOPMENT
The functional involvement of epigenetic regulation in both cancer initiation and progression in vivo has been highlighted by previous studies. Particularly noteworthy are detailed studies using Apcmutant mice that have revealed the consequence of modified DNA methylation in colon tumor development. [53] [54] [55] [56] These studies suggest that forced reduction in DNA methylation causes chromosomal instability, resulting in the loss of Apc heterozygosity, and eventually promotes neoplastic transformation of colonic mucosa; however, at the same time, it suppresses the progression of early microadenomas into macroscopic tumors. In addition, the overexpression of de novo DNA methyltransferase Dnmt3b accelerates the progression of colonic microadenoma to a macroscopic tumor, whereas deletion of Dnmt3b suppresses this progression. In contrast, the forced reduction in DNA methylation induces liver cancers in the same model.
Together, these in vivo studies suggest that DNA methylation plays a critical role in cancer development but has different effects depending on the cellular context and the stage of tumorigenesis.
| ENVIRONMENTAL FACTORS CAUSE EPIGENETIC ALTERATIONS IN CANCER
The available data suggest that cancer progresses through multistep processes involving both genetic mutations and epigenetic expression leads to more efficient and faster reprogramming in both human and mouse cells. 64, 65 In contrast, fibroblasts from older mice, which express higher levels of Ink4b/ Arf/Ink4a locus products, are less efficiently reprogrammable to iPSCs, 66 further linking aging/senescence with decreased reprogramming efficiency.
Senescent cells
Notably, the induction of senescence is similarly observed in the early stage of cancer development where the increased expressions of tumor suppressor genes are detectable at preneoplastic lesions. It is therefore suggested that the proliferation arrest that is associated with senescence acts as a safeguard for malignant transformation, providing a close link between senescence escape and neoplastic growth. Collectively, senescence could be a critical roadblock for both cell reprogramming and cancer development, which underscores the similarity between these two processes.
| SH ARED EPIGENE TIC ALTERATIONS BETWEEN SEN ESCENT CELLS AND CANCER CELLS
Although the molecular mechanisms underlying escape from senescence during cancer development are often explained by genetic aberrations such as inactivating mutations at the TP53 and CDKN2A genes, it is still possible that epigenetic regulation plays an important role, especially in cancers that lack genetic mutations in senescence- | 2645
| INTERVENTION FOR EPIGENETIC REGULATION IN SE NESCE NT CELLS AND CANCER CELLS WITH REPROGRAMMING TECHNOLOGY
By necessity, a dynamic reorganization of epigenetic regulation occurs during reprogramming, whereas changes in the underlying genomic information are not required. Therefore, reprogramming technology could be a useful strategy for actively manipulating epigenetic regulation. Of particular interest, previous studies have
shown that age-associated DNA methylation changes can be reverted by somatic cell reprogramming into iPSCs in vitro. 43 Notably, reprogramming by OSKM resets cellular damage-associated, stress-associated, and senescence-associated epigenetic marks in vitro. 68, 69, 70 Consistently, the reprogramming of cells from elderly humans into pluripotent cells erases many of the hallmarks of aging and restores a youthful gene expression profile that is maintained during differentiation. This effect suggests that, in addition to telomere elongation, age/senescence-associated epigenetic parameters can be reprogrammed with iPSC technology. 71 These observations fit the general assumption that iPSCs are fully rejuvenated ( Figure 3 ). It is noteworthy that some age-associated phenotypes are sustained in neurons induced from old cells through direct reprogramming, suggesting that passage through the pluripotent state might be necessary for complete abrogation of the aging clock. 
| ANTI-AGING STRATEGY WITH IN VIVO REPROGRAMMING
Previous studies have described in vivo approaches to induce organismal rejuvenation and extend lifespans. Heterochronic parabiosis, a technique that links the circulatory systems of an old and young animal, can rejuvenate several hallmarks of aging in the older animal. 75 The elimination of p16-positive senescent cells is shown to extend lifespans in both progeria and normal mouse. 76, 77 Considering that in vitro cell reprogramming abrogates senescence-associated epigenetic alterations, researchers have investigated whether OSKM-induced reprogramming has beneficial effects on aging phenotypes at organismal levels. 12 Interestingly, cyclic short-term induction (2 days) of OSKM in vivo dampens aging-asso- 
| UNCOVERING A UNIQUE CANCER DRIVER WITH IN VIVO RE PROGRAMMIN G TECHNOLOGY
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| UNVEILING NONCELL AUTONOMOUS EFFECTS OF SENESCENT CELLS ON ENHANCED CELLULAR PLASTICITY
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